Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 S Landmark Ave
Bloomington, IN 47403Phone+1 812-333-5973
Summary
- Dr. Thomas Lu is a gastroenterologist in Bloomington, IN and is affiliated with Indiana University Health - Bloomington. He received his medical degree from University of Cincinnati College of Medicine and completed his Internal Medicine residency and Gastroenterology fellowship training at the University of Chicago Medicine. He specializes in inflammatory bowel disease.
Education & Training
- University of ChicagoFellowship, Gastroenterology, 2015 - 2019
- University of ChicagoResidency, Internal Medicine, 2013 - 2015
- University of Cincinnati College of MedicineClass of 2013
Certifications & Licensure
- IL State Medical License 2015 - 2026
- IN State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 22 citationsYTHDF2/mA/NF-κB axis controls anti-tumor immunity by regulating intratumoral Tregs.Linda Zhang, Xiaoyang Dou, Zhong Zheng, Chang Ye, Thomas X Lu
The EMBO Journal. 2023-08-01 - 15 citationsThe influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controll...Thomas X. Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba
Gut. 2021-11-01 - 22 citationsContraction Reserve With Ineffective Esophageal Motility on Esophageal High-Resolution Manometry is Associated With Lower Acid Exposure Times Compared With Absent Cont...Farhan Quader, Benjamin D. Rogers, Tyson Sievers, Shaham Mumtaz, Mindy W. Lee
The American Journal of Gastroenterology. 2020-12-01
Journal Articles
- The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controll...Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba, Gut, 12/17/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: